Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers-Reference-Cited by-同舟云学术

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

Published:2007-11-25 Issue:2 Volume:47 Page:455-460
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Guha Indra Neil,Parkes Julie,Roderick Paul,Chattopadhyay Dipanker,Cross Richard,Harris Scott,Kaye Philip,Burt Alastair D.,Ryder Steve D.,Aithal Guruprasad P.,Day Christopher P.,Rosenberg William M.

Publisher

Wiley

Subject

Hepatology

Reference11 articles.

1. The natural history of nonalcoholic fatty liver disease: a population-based cohort study;Adams;Gastroenterology,2005

2. Long-term follow-up of patients with NAFLD and elevated liver enzymes;Ekstedt;HEPATOLOGY,2006

3. Practices of liver biopsy in France: results of a prospective nationwide survey;Cadranel;HEPATOLOGY,2000

4. Sampling variability of liver biopsy in nonalcoholic fatty liver disease;Ratziu;Gastroenterology,2005

5. Serum markers detect the presence of liver fibrosis: a cohort study;Rosenberg;Gastroenterology,2004

Cited by 632 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Validation Study of Non-invasive Scoring Systems for Assessing Severity of Hepatic Fibrosis in a Cohort of South Indian Patients With Non-alcoholic Fatty Liver Disease;Journal of Clinical and Experimental Hepatology;2024-09

2. Variation in liver function testing and the effect of pyridoxal-5-phosphate on ALT, AST and FIB-4 results;Annals of Clinical Biochemistry: International Journal of Laboratory Medicine;2024-08-05

3. Identifying and Linking Patients At Risk for MASLD with Advanced Fibrosis to Care in Primary Care;Journal of General Internal Medicine;2024-07-26

4. A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD;Seminars in Liver Disease;2024-07-11

5. Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic-Dysfunction-Associated Steatohepatitis;Seminars in Liver Disease;2024-07-09